These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34061590)

  • 1. Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole.
    Siscar-Lewin S; Gabaldón T; Aldejohann AM; Kurzai O; Hube B; Brunke S
    mBio; 2021 Jun; 12(3):e0112821. PubMed ID: 34061590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.
    Ferrari S; Sanguinetti M; Torelli R; Posteraro B; Sanglard D
    PLoS One; 2011 Mar; 6(3):e17589. PubMed ID: 21408004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.
    Steier Z; Vermitsky JP; Toner G; Gygax SE; Edlind T; Katiyar S
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5543-7. PubMed ID: 23979762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.
    Schulz B; Knobloch M; Weber K; Ruhnke M
    Int J Med Microbiol; 2012 Jul; 302(3):155-61. PubMed ID: 22664377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice.
    Ferrari S; Sanguinetti M; De Bernardis F; Torelli R; Posteraro B; Vandeputte P; Sanglard D
    Antimicrob Agents Chemother; 2011 May; 55(5):1852-60. PubMed ID: 21321146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Transcriptomics Approach To Unveiling the Mechanisms of
    Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
    Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.
    Minematsu A; Miyazaki T; Shimamura S; Nishikawa H; Nakayama H; Takazono T; Saijo T; Yamamoto K; Imamura Y; Yanagihara K; Kohno S; Mukae H; Izumikawa K
    PLoS One; 2019; 14(1):e0210883. PubMed ID: 30673768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Milbemycins: more than efflux inhibitors for fungal pathogens.
    Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
    Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
    Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
    Panackal AA; Gribskov JL; Staab JF; Kirby KA; Rinaldi M; Marr KA
    J Clin Microbiol; 2006 May; 44(5):1740-3. PubMed ID: 16672401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and ρ0 cells.
    Paul S; Bair TB; Moye-Rowley WS
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6904-12. PubMed ID: 25199772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants.
    Tsai HF; Krol AA; Sarti KE; Bennett JE
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1384-92. PubMed ID: 16569856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole resistance in Candida glabrata is associated with increased bud formation and metallothionein production.
    Samaranayake YH; Cheung BPK; Wang Y; Yau JYY; Yeung KWS; Samaranayake LP
    J Med Microbiol; 2013 Feb; 62(Pt 2):303-318. PubMed ID: 23002065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.